Susquehanna International Group, LLP Amarin Corp Plcuk Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Amarin Corp Plcuk stock. As of the latest transaction made, Susquehanna International Group, LLP holds 195,927 shares of AMRN stock, worth $90,126. This represents 0.0% of its overall portfolio holdings.

Number of Shares

195,927

Previous 105,495 85.72%

Holding current value

$90,126

Previous $72,000 70.83%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$0.57 - $0.8 $51,546 - $72,345	90,432 Added 85.72%	195,927 $123,000
Q2 2024 Aug 15, 2024	BUY	$0.63 - $1.07 $66,461 - $112,879	105,495 New	105,495 $72,000
Q4 2023 Feb 14, 2024	BUY	$0.66 - $0.91 $178,788 - $246,510	270,891 Added 67.0%	675,203 $587,000
Q3 2023 Nov 14, 2023	SELL	$0.85 - $1.43 $56,289 - $94,698	-66,223 Reduced 14.07%	404,312 $371,000
Q2 2023 Aug 11, 2023	BUY	$1.12 - $1.49 $165,943 - $220,764	148,164 Added 45.96%	470,535 $559,000
Q1 2023 May 16, 2023	SELL	$1.19 - $2.19 $840,405 - $1.55 Million	-706,223 Reduced 68.66%	322,371 $483,000
Q4 2022 Feb 14, 2023	SELL	$1.07 - $1.34 $519,737 - $650,886	-485,736 Reduced 32.08%	1,028,594 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$1.09 - $1.67 $284,757 - $436,279	261,245 Added 20.85%	1,514,330 $1.65 Million
Q2 2022 Aug 15, 2022	BUY	$1.13 - $3.69 $385,219 - $1.26 Million	340,902 Added 37.37%	1,253,085 $1.87 Million
Q1 2022 May 16, 2022	SELL	$2.85 - $3.73 $2.12 Million - $2.77 Million	-743,731 Reduced 44.91%	912,183 $3 Million
Q4 2021 Feb 14, 2022	SELL	$3.24 - $5.18 $413,035 - $660,346	-127,480 Reduced 7.15%	1,655,914 $5.58 Million
Q3 2021 Nov 15, 2021	SELL	$3.94 - $5.84 $1.22 Million - $1.8 Million	-308,926 Reduced 14.76%	1,783,394 $9.1 Million
Q2 2021 Aug 11, 2021	SELL	$4.26 - $6.5 $4.42 Million - $6.75 Million	-1,038,277 Reduced 33.17%	2,092,320 $9.16 Million
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $1.64 Million - $2.88 Million	-327,032 Reduced 9.46%	3,130,597 $19.4 Million
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $3 Million - $3.95 Million	743,317 Added 27.39%	3,457,629 $16.9 Million
Q3 2020 Nov 16, 2020	SELL	$3.64 - $7.76 $138,210 - $294,647	-37,970 Reduced 1.38%	2,714,312 $11.4 Million
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $7.45 Million - $12.9 Million	-1,559,107 Reduced 36.16%	2,752,282 $19 Million
Q1 2020 May 15, 2020	SELL	$4.0 - $21.53 $1.04 Million - $5.61 Million	-260,338 Reduced 5.69%	4,311,389 $17.2 Million
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $13.8 Million - $23.9 Million	-990,075 Reduced 17.8%	4,571,727 $98 Million
Q3 2019 Nov 14, 2019	BUY	$13.89 - $23.16 $31.7 Million - $52.9 Million	2,283,058 Added 69.63%	5,561,802 $84.3 Million
Q2 2019 Aug 16, 2019	BUY	$16.27 - $20.51 $102,793 - $129,582	6,318 Added 0.19%	3,278,744 $63.6 Million
Q2 2019 Aug 14, 2019	SELL	$16.27 - $20.51 $7.77 Million - $9.79 Million	-477,482 Reduced 12.73%	3,272,426 $63.5 Million
Q1 2019 May 15, 2019	BUY	$12.61 - $22.33 $7.24 Million - $12.8 Million	574,054 Added 18.08%	3,749,908 $77.8 Million
Q4 2018 Feb 14, 2019	SELL	$12.41 - $22.98 $153,908 - $284,997	-12,402 Reduced 0.39%	3,175,854 $43.2 Million
Q3 2018 Nov 14, 2018	BUY	$2.45 - $16.27 $3.58 Million - $23.8 Million	1,462,881 Added 84.79%	3,188,256 $51.9 Million
Q2 2018 Aug 14, 2018	SELL	$2.68 - $3.48 $743,204 - $965,056	-277,315 Reduced 13.85%	1,725,375 $5.33 Million
Q1 2018 May 15, 2018	BUY	$2.99 - $4.44 $4.59 Million - $6.81 Million	1,534,704 Added 327.94%	2,002,690 $6.03 Million
Q4 2017 Feb 14, 2018	BUY	$3.06 - $4.09 $286,777 - $383,306	93,718 Added 25.04%	467,986 $1.88 Million
Q3 2017 Nov 20, 2017	BUY	$3.03 - $3.72 $1.13 Million - $1.39 Million	374,268	374,268 $1.31 Million

Others Institutions Holding AMRN

# of Institutions

177

Shares Held

65.1M

Call Options Held

258K

Put Options Held

98K

View Full List

About AMARIN CORP PLCUK

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $185M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

More about AMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Amarin Corp Plcuk Transaction History